cbdMD Inc. logo

cbdMD Inc.

YCBD | AMEX
Chart Builder DCF Calculator
$0.50
-$0.02 (-3.86%)
At close: Aug 27, 2026, 3:59 PM ET

Company Profile

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.

Key Executives

Name Position
T. Ronan Kennedy Chief Executive Officer, Chief Financial Officer, Principal Executive Officer & Director
Shannon Charles Chief Marketing Officer
Wade Brown Chief Marketing Officer
Zeb Booker Chief Technology Officer
Bradley Whitford Chief Accounting Officer, Treasurer & Secretary
David Johnson Senior Vice President of Business Development
Francisco Mangual Senior Vice President of Sales
Lance Blundell General Counsel
Sibyl Swift CSO, Vice President of Regulatory Affairs & Director

Latest SEC Filings

Date Type Title
May 20, 2026 8-K Current Report
May 14, 2026 10-Q Quarterly Report
Apr 16, 2026 4 Filing
Apr 16, 2026 4 Filing
Apr 16, 2026 4 Filing
Apr 16, 2026 4 Filing
Apr 16, 2026 4 Filing
Apr 16, 2026 4 Filing
Apr 15, 2026 8-K Current Report
Apr 01, 2026 8-K Current Report
View All SEC Filings ➞
cbdMD Inc.
cbdMD Inc. logo
Country United States
IPO Date Nov 17, 2017
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 42
CEO T. Ronan Kennedy

Contact Details

2101 Westinghouse Blvd Charlotte, North Carolina 28217 United States

Stock Details

Ticker Symbol YCBD
Exchange AMEX
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001644903
CUSIP Number 12482W408
ISIN Number US12482W4087
SIC Code 2844

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.